4.6 Review

Nanoparticles and mesenchymal stem cells: a win-win alliance for anticancer drug delivery

Journal

RSC ADVANCES
Volume 6, Issue 43, Pages 36910-36922

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/c6ra00398b

Keywords

-

Funding

  1. National Natural Science Foundation of China [81102398, 81273469]
  2. Natural Science Foundation of Jiangsu Province [BK2011624]
  3. Ministry of Education Doctoral Program of Higher Specialized Research Fund [20110096120003, 20113234120008]
  4. Fundamental Research Funds for the Central Universities [JKVD2013011]
  5. State Key Laboratory of Natural Medicines, China Pharmaceutical University [SKLNMKF201305, SKLNMKF201215]
  6. National Found for Fostering Talents of Basic Science [J1030830]

Ask authors/readers for more resources

The development of nanoparticles (NPs) provides anticancer therapy with new strategies, such as noninvasive imaging and targeted drug delivery. However, uneven intratumoral distribution and immunogenicity hinder the clinical applications of NPs. Currently, mesenchymal stem cells (MSCs) are emerging as a hotspot in anticancer drug delivery due to their intrinsic characteristics, such as tumor-tropism and low immunogenicity. Herein, the combination of MSCs and NPs offers an advanced option to overcome the limitations of NPs. On the other hand, NPs could benefit MSC-based drug delivery systems in many aspects. Firstly, genetic modification is currently used in the design of cell vectors. More and more researchers prefer to use NPs to introduce exogenous genes into MSCs due to the lower risk of NPs compared with viral vectors. Secondly, as drug carriers, NPs could effectively protect MSCs from direct interaction with chemotherapy drugs and control the drug release profile of NPs-MSCs. Thirdly, some NPs exhibit a distinct promoting effect on the proliferation and migration of MSCs, which are beneficial to successful cell-based drug delivery. In the past few years, progress has been made in the combination of MSCs and NPs for treating cancer though the combined system is still in its infancy stage. Therefore, an overview of the current paradigm of the novel combined tumor-targeted drug delivery system is urgently demanded to provide valuable information for future clinical transformations of this combined drug delivery system.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Chemistry, Multidisciplinary

Combining nanotechnology with the multifunctional roles of neutrophils against cancer and inflammatory disease

Lu Tang, Shun He, Yue Yin, Jing Li, Qiaqia Xiao, Ruotong Wang, Lijun Gao, Wei Wang

Summary: This article introduces neutrophils as a promising platform for cancer and inflammatory disease treatment and discusses the recent advancements in the application of nanomaterials in neutrophil-based therapies. It explores how nanomaterials improve treatment efficacy and overcome their limitations, and outlines emerging therapeutic strategies targeting neutrophils and novel approaches for COVID-19-related treatments.

NANOSCALE (2022)

Review Medicine, Research & Experimental

Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives

Lu Tang, Jing Li, Ting Pan, Yue Yin, Yijun Mei, Qiaqia Xiao, Ruotong Wang, Ziwei Yan, Wei Wang

Summary: Despite advancements in medicine, cancer remains a leading cause of death worldwide. Traditional treatment strategies often come with severe adverse effects and limited efficacy. Nanotechnology, particularly carbon nanomaterials, has shown great promise in cancer therapy due to their unique properties. Developing carbon-based nanoplatforms is critical for improving cancer theranostics. This review introduces the use of graphene, graphdiyne, fullerene, carbon nanotubes, and carbon quantum dots in cancer treatment, as well as their diagnostic potential.

THERANOSTICS (2022)

Article Pharmacology & Pharmacy

A General Small-Angle X-ray Scattering-Based Screening Protocol for Studying Physical Stability of Protein Formulations

Fangrong Zhang, Gesa Richter, Benjamin Bourgeois, Emil Spreitzer, Armin Moser, Andreas Keilbach, Petra Kotnik, Tobias Madl

Summary: This study presents a workflow for screening protein formulations using SAXS, demonstrating its advantages over DLS in measuring protein particle interactions and long-term stability.

PHARMACEUTICS (2022)

Review Oncology

Multifunctional inorganic nanomaterials for cancer photoimmunotherapy

Lu Tang, Aining Zhang, Ziyao Zhang, Qingqing Zhao, Jing Li, Yijun Mei, Yue Yin, Wei Wang

Summary: Combining immunotherapy and phototherapy is considered the ideal approach for treating tumors. Inorganic nanomaterials, with their unique physicochemical properties, play a crucial role in photoimmunotherapy (PIT) by serving as carriers for immunomodulatory agents and as photothermal agents or photosensitizers in phototherapy.

CANCER COMMUNICATIONS (2022)

Article Materials Science, Multidisciplinary

Rhamnolipid-assisted black phosphorus nanosheets with efficient isolinderalactone loading against drug resistant Helicobacter pylori

Yanqiang Huang, Rujia Li, Yuanyuan Dai, Chun Qin, Jikai He, Shixian Yang, Tengqi Wang, Yujie Su, Lizhou Jia, Wei Zhao

Summary: This study engineered a multifunctional nanodrug, RHL@BP, for the treatment of drug resistant H. pylori infection. The nanodrug efficiently delivered ISL, an active compound from traditional Chinese medicine, to enhance its antibacterial effect against drug resistant H. pylori under near-infrared irradiation. The controlled release of ISL triggered by the acid sensitivity of BP and photothermal instability of RHL exhibited significant synergistic antibacterial activity against drug resistant H. pylori. The study demonstrates a potential strategy for the clinical treatment of drug resistant H. pylori infections.

MATERIALS & DESIGN (2022)

Review Pharmacology & Pharmacy

Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer

Jin Gao, Yujie Su, Zhenjia Wang

Summary: This review provides an overview of the current research on bacterial membrane vesicles (BMVs), including their production, types, and therapeutic applications. The authors discuss various platforms of BMVs and how they can be engineered using chemical, physical, and genetic methods. The review also examines the methods of drug loading in BMVs and their limitations. Several therapeutic platforms of BMVs for improving the treatment of infectious diseases and cancers are reviewed. The authors emphasize the need for rigorous approaches and methods to develop reproducible and scalable drug delivery systems for translation.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Article Engineering, Biomedical

Macrophage membrane-camouflaged lipoprotein nanoparticles for effective obesity treatment based on a sustainable self-reinforcement strategy

Yujie Su, Wei Wang, Qiaqia Xiao, Lu Tang, Tingting Wang, Mengying Xie, Yangnan Su

Summary: Modern lifestyle has led to an increase in obesity, and current anti-obesity medications have limited efficacy and severe side effects. This study developed a drug delivery platform based on a macrophage cell membrane-coated recombinant high-density lipoprotein (rHDL) to selectively deliver therapeutic drugs to adipose tissue. By combining rosiglitazone and sildenafil, the study achieved a synergistic therapeutic outcome in regulating diet-induced obesity in a mice model. The treatment resulted in significant weight reduction and improved metabolic status. Moreover, the delivery system demonstrated a sustainable self-reinforcement effect, enhancing the accumulation of drugs in adipose tissue for subsequent administrations.

ACTA BIOMATERIALIA (2022)

Article Materials Science, Multidisciplinary

A minimally designed PD-L1-targeted nanocomposite for positive feedback-based multimodal cancer therapy

Yijun Mei, Lu Tang, Lidong Zhang, Jingyi Hu, Ziyao Zhang, Shun He, Jing Zang, Wei Wang

Summary: Combining immune checkpoint blockade therapy with other treatment modalities through nanotechnology can enhance immunity for effective cancer treatment. In this study, a three-in-one nanocomposite was fabricated, which could precisely target tumors and strengthen the antitumor efficacy through the interaction of different components. The combination therapy demonstrated a positive feedback-mediated multimodal antitumor effect and the potential for long-term tumor immune memory establishment.

MATERIALS TODAY (2022)

Review Materials Science, Biomaterials

Harnessing nanobiotechnology for cerebral ischemic stroke management

Lu Tang, Cong Fu, Aining Zhang, Xiyue Li, Yuqi Cao, Jingwen Feng, Hening Liu, Haijuan Dong, Wei Wang

Summary: Cerebral ischemic stroke is a serious neurological disorder that leads to long-term disability or death worldwide. Nanobiotechnology offers new insights and alternatives for effective management of ischemic stroke by overcoming the limitations of conventional treatment methods. This review highlights the recent achievements in using diverse nanoplatforms for targeted delivery and therapeutic approaches against ischemic stroke, including neuroprotection, anti-inflammation, thrombolysis, blood-brain barrier penetration, and reactive oxygen species scavenging. The rational design of versatile nanoplatforms and the challenges, opportunities, and future perspectives in nanobiotechnology for ischemic stroke management are also discussed.

BIOMATERIALS SCIENCE (2023)

Article Pharmacology & Pharmacy

Lung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner

Jin Gao, Yujie Su, Zhenjia Wang

Summary: Inflammation resolution is achieved through specialized pro-resolving mediators, such as RvD1 and RvD2, which have been shown to benefit the treatment of inflammation disorders. These mediators regulate interactions between endothelial cells and neutrophils in the lung, promoting resolution of lung inflammation.

PHARMACEUTICS (2023)

Proceedings Paper Automation & Control Systems

Spatial-Temporal Evidence Combination Method for Multi-sensor Target Recognition Based on Prospect Theory

Zihan Zhang, Zhentao Hu, Junwei Li, Yujie Su

Summary: The study uses evidence theory to achieve spatial-temporal fusion of target recognition information. By introducing prospect value function and credibility decay model, spatial-temporal evidence is adjusted and combined, considering the dynamic and sequential characteristics. The numerical simulation results show that this method can handle conflict information and is more reasonable.

2022 7TH INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION ENGINEERING, ICRAE (2022)

Proceedings Paper Computer Science, Interdisciplinary Applications

An End-to-end Posture Perception Method for Soft Bending Actuators Based on Kirigami-inspired Piezoresistive Sensors

Jing Shu, Junming Wang, Yujie Su, Honghai Liu, Zheng Li, Raymond Kai-Yu Tong

Summary: This paper presents a posture perception method for soft actuators using long short-term memory (LSTM) neural networks and a novel flexible bending sensor. The method was validated on a finger-size one DOF pneumatic fiber-reinforced bending actuator and showed accurate posture sensing.

2022 IEEE-EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL AND HEALTH INFORMATICS (BHI'22) JOINTLY ORGANISED WITH THE IEEE-EMBS INTERNATIONAL CONFERENCE ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS (BSN'22) (2022)

Proceedings Paper Engineering, Biomedical

Observer Based Sliding Mode Control for a Knee Exoskeleton

Yujie Su, Wuxiang Zhang, Xilung Ding

Summary: In this study, an observer based sliding mode control method is proposed to solve the problems in estimation and controlling caused by disturbance in a knee exoskeleton. A sliding mode disturbance observer is designed to estimate the disturbance, followed by impedance control for human-robot interaction control. The results demonstrate that the proposed method performs better in estimating and controlling in the presence of unknown disturbance.

NEW TRENDS IN MEDICAL AND SERVICE ROBOTICS (2022)

Article Materials Science, Biomaterials

An enzyme-responsive and NIR-triggered lipid-polymer hybrid nanoplatform for synergistic photothermal/chemo cancer therapy

Lu Tang, Qiaqia Xiao, Yue Yin, Yijun Mei, Jing Li, Lin Xu, Hongbin Gao, Wei Wang

Summary: This study successfully developed a novel nanoplatform based on a lipid-polymer hybrid system for targeted cancer treatment by co-loading photothermal and chemotherapeutic drugs. The nanoplatform demonstrated good stability, imaging properties, and significant inhibitory effect on tumor growth.

BIOMATERIALS SCIENCE (2022)

No Data Available